(ADGM) Adagio Medical Holdings - Ratings and Ratios

Adagio Medical Holdings, Inc. (NASDAQ:ADGM) is a developmental-stage medical device company specializing in innovative ablation technologies for treating cardiac arrhythmias. Its product portfolio includes the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories, designed for precise and efficient treatment of atrial fibrillation and flutter. The company also offers the vCLAS ventricular ULTC catheter for addressing ventricular tachycardia, alongside the Cryopulse atrial pulsed-field cryoablation catheter and accessories. Founded in 2011 and headquartered in Laguna Hills, California, Adagio Medical Holdings focuses on advancing cryoablation technologies to improve outcomes for patients with cardiac arrhythmias. The companys approach combines ultra-low temperature cryoablation with pulsed-field technology, aiming to provide safer and more effective treatments compared to traditional methods.

Based on the provided data, the 3-month forecast for Adagio Medical Holdings, Inc. (NASDAQ:ADGM) suggests the following trends: - Technical Outlook: The stock is currently trading below its 20-day and 50-day simple moving averages (SMA), indicating bearish momentum. The 200-day SMA of 2.67 suggests a potential long-term downtrend. Average trading volume of 178,188 shares over 20 days and an ATR of 0.16 indicate moderate volatility. - Fundamental Outlook: With a market cap of $54.65M and a price-to-sales ratio of 205.44, the stock is priced at a premium relative to its revenue. The return on equity (RoE) of 0.56% reflects limited profitability. Given the developmental stage of the company and the absence of P/E and forward P/E ratios, investors should focus on operational progress and potential catalysts in the near term. - Price Forecast: Based on technical and fundamental factors, the stock is expected to trade in a range of $0.90 to $1.35 over the next three months, with potential resistance at the 50-day SMA of 1.12 and support at the ATR-based lower bound of $0.91.